Skip to main content

Hoba Therapeutics

Copenhagen, Denmark

Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.

$24.8M raised
Dec 2023
Series A

Top Investors

Novo HoldingsEuropean Innovation CouncilIndaco Venture PartnersEIR VenturesExport and Investment Fund

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Hoba Therapeutics

How much funding has Hoba Therapeutics raised?
Hoba Therapeutics has raised $24.8M in total funding. The most recent round was Series A. The last funding was announced in December 2023.
Who are Hoba Therapeutics's investors?
Hoba Therapeutics's investors include Novo Holdings, European Innovation Council, Indaco Venture Partners, EIR Ventures, Export and Investment Fund.
Where is Hoba Therapeutics headquartered?
Hoba Therapeutics is headquartered in Copenhagen, Denmark.
What does Hoba Therapeutics do?
Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
What stage is Hoba Therapeutics at?
Hoba Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Hoba Therapeutics — Funding & Investors." VCBacked, December 11, 2023, https://www.vcbacked.co/company/hoba-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2023). Hoba Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/hoba-therapeutics
Wikipedia (cite web)
{{cite web |title=Hoba Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/hoba-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .